Concepedia

Annalisa Romanelli

AR

Statistics

Publications

6

Citations

274

H-Index

6

Active since

2019

Affiliations

Sapienza University of Rome(Current)

University of Campania "Luigi Vanvitelli"

Istituti di Ricovero e Cura a Carattere Scientifico

National Research Council

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Annalisa Romanelli is an author at Sapienza University of Rome specializing in pharmacology, cancer pharmacology, and epigenetics.

Publications per year

2019–2021

6

Publications

6

Design of First-in-Class Dual EZH2/HDAC Inhibitor: Biochemical Activity and Biological Evaluation in Cancer Cells

Annalisa Romanelli, Giulia Stazi, Rossella Fioravanti et al. · ACS Medicinal Chemistry Letters · 2020 · 76 citations · Full text

, , +16

RETRACTED ARTICLE: Dissecting the role of novel EZH2 inhibitors in primary glioblastoma cell cultures: effects on proliferation, epithelial-mesenchymal transition, migration, and on the pro-inflammatory phenotype

Giulia Stazi, Ludovica Taglieri, Alice Nicolai et al. · Clinical Epigenetics · 2019 · 61 citations · Full text

, , +17

Polycomb Repressive Complex 2 Modulation through the Development of EZH2–EED Interaction Inhibitors and EED Binders

Stefano Tomassi, Annalisa Romanelli, Clemens Zwergel et al. · Journal of Medicinal Chemistry · 2021 · 50 citations · Full text

, , +16

Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma

Wesam Ali, Gabriella Spengler, Annamária Kincses et al. · European Journal of Medicinal Chemistry · 2020 · 45 citations · Full text

, , +16

Tranylcypromine‐Based LSD1 Inhibitors: Structure‐Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target Modulation

Rossella Fioravanti, Annalisa Romanelli, Nicola Mautone et al. · ChemMedChem · 2020 · 32 citations · Full text

, , +15

1–5 of 6